Amwell (AMWL) announced the expansion of its digital clinical programs to include a cardiometabolic program, enabling health plans and clinicians to seamlessly connect members living with common chronic diseases, such as diabetes and high blood pressure, to Dario’s highly personalized digital therapeutic solution on the Amwell platform. In partnership with personalized global digital therapeutic leader DarioHealth (DRIO), the new cardiometabolic program builds upon the comprehensive Amwell portfolio of care solutions and network of affiliated clinicians, designed to address member needs both in and outside the provider office. "Member care and engagement are top-of-mind for health plans, especially as consumers demand more digital tools and effective, value-driven care," says Dr. Ido Schoenberg, chairman and co-CEO of Amwell. "By bringing solutions like Dario into our ecosystem of care programs, Amwell empowers health plans and their clinicians to create a more cohesive, integrated, and comprehensive digital journey for their members. It’s an approach that ultimately drives better outcomes and more modernized engagement. This new capability further expands the scope of our single, highly scalable platform powered by Converge(TM). It adds yet another important component in delivering our clients ‘one stop shop’ digital care enablement solution, addressing their most important and diversified needs today while being future ready."
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on AMWL:
